-
EP4256311
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4256311
| EP4256311 - ADMINISTRATION OF ANTI-TUMOR VACCINES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 08.09.2023 Database last updated on 19.10.2024 | |
| Former | The international publication has been made Status updated on 17.06.2022 | Most recent event Tooltip | 18.03.2024 | Amendment by applicant | Applicant(s) | For all designated states Iogenetics, LLC. 3591 Anderson Street Suite 218 Madison, Wisconsin 53704 / US | For all designated states Asthra, LLC 15332 Antioch Street, 599 Pacific Palisades, CA 90272 / US | [2023/41] | Inventor(s) | 01 /
HOMAN, Jane Madison, Wisconsin 53704 / US | 02 /
BREMEL, Robert D. Madison, Wisconsin 53704 / US | 03 /
KESARI, Santosh Pacific Palisades, California 90272 / US | [2023/41] | Representative(s) | Algemeen Octrooi- en Merkenbureau B.V. P.O. Box 645 5600 AP Eindhoven / NL | [2023/41] | Application number, filing date | 21904224.9 | 07.12.2021 | [2023/41] | WO2021US62147 | Priority number, date | US202063122192P | 07.12.2020 Original published format: US 202063122192 P | [2023/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022125511 | Date: | 16.06.2022 | Language: | EN | [2022/24] | Type: | A1 Application with search report | No.: | EP4256311 | Date: | 11.10.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.06.2022 takes the place of the publication of the European patent application. | [2023/41] | Search report(s) | International search report - published on: | US | 16.06.2022 | Classification | IPC: | G01N21/65, G01N33/50, G01N33/53 | [2023/41] | CPC: |
A61P35/00 (EP,US);
A61K39/0011 (EP,US);
A61K39/001162 (EP,US);
A61K39/4611 (EP,US);
A61K39/464462 (EP,US);
C12Q1/6886 (US);
G01N33/57484 (US);
A61K2039/545 (EP);
A61K2039/57 (EP);
A61K2039/572 (EP);
A61K2039/575 (US);
A61K2039/70 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/41] | Title | German: | VERABREICHUNG VON ANTITUMORIMPFSTOFFEN | [2023/41] | English: | ADMINISTRATION OF ANTI-TUMOR VACCINES | [2023/41] | French: | ADMINISTRATION DE VACCINS ANTITUMORAUX | [2023/41] | Entry into regional phase | 28.06.2023 | National basic fee paid | 28.06.2023 | Search fee paid | 28.06.2023 | Designation fee(s) paid | 28.06.2023 | Examination fee paid | Examination procedure | 28.06.2023 | Examination requested [2023/41] | 18.03.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.12.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US2017096461 (MAHR ANDREA [DE], et al); | [A]US2020390873 (HOMAN JANE [US], et al) |